Peregrine Capital Management LLC Invitae Corp Transaction History

Peregrine Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 17, 2020	SELL	$7.64 - $27.5 $5.67 Million - $20.4 Million	-742,319 Closed	0 $0
Q4 2019 Jan 16, 2020	BUY	$15.02 - $20.57 $715,042 - $979,255	47,606 Added 6.85%	742,319 $12 Million
Q3 2019 Oct 16, 2019	SELL	$18.85 - $27.5 $144,108 - $210,237	-7,645 Reduced 1.09%	694,713 $13.4 Million
Q2 2019 Jul 18, 2019	BUY	$17.37 - $26.27 $1.07 Million - $1.62 Million	61,488 Added 9.59%	702,358 $0
Q1 2019 Apr 12, 2019	BUY	$10.65 - $25.75 $6.83 Million - $16.5 Million	640,870 New	640,870 $0

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Peregrine Capital Management LLC with notifications on news.